Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

Biotechnology

Healthcare
$8.44 +3.04%

+$0.26 today

Market cap
$547.12M
Beta
1.80
P/E (TTM)
-1.7
EPS (TTM)
-$5.11
52W Low $5.37High $17.58

Volume 2.36M

Average 1.24M

Income Statement

Follow revenue through to earnings.

Revenue

$170.16M

FY 2025 · Annual

-25.1% YoY

Operating Income

-$315.28M

FY 2025 · Annual

Net Income

-$312.76M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue313.84M477.71M251.46M227.04M170.16M
Cost of Revenue129.69M204.22M54.01M38.55M31.52M
Gross Profit184.15M273.49M197.45M188.49M138.63M
Gross Margin58.7%57.3%78.5%83.0%81.5%
Research & Development1.15B1.05B580.62M424.06M243.77M
Selling, General & Admin862.95M1.43B385.03M246.16M183.29M
Operating Expenses2.01B2.48B1.06B748.25M453.91M
Depreciation & Amortization29.08M61.63M71.55M63.02M58.99M
EBITDA(1.81B)(2.06B)(821.29M)(484.39M)(254.61M)
EBITDA Margin-575.7%-431.2%-326.6%-213.3%-149.6%
Operating Income(1.83B)(2.21B)(864.41M)(559.76M)(315.28M)
Operating Margin-582.6%-462.4%-343.8%-246.5%-185.3%
Interest Income837K20.26M57.22M38.61M22.62M
Interest Expense2.37M106K93K94K0
Other Income / Expenses(9.66M)87.55M(28.53M)12.25M1.68M
Income Before Tax(1.84B)(2.12B)(892.94M)(547.51M)(313.6M)
Pre-Tax Margin-585.7%-444.1%-355.1%-241.1%-184.3%
Income Tax Expense(1.48M)(15.03M)(71K)(479K)(837K)
Net Income(1.83B)(2.1B)(892.87M)(547.03M)(312.76M)
Net Margin-583.1%-440.6%-355.1%-240.9%-183.8%
EPS (Basic)(53.83)(50.15)(18.37)(10.54)(5.64)
EPS (Diluted)(55.53)(50.20)(18.40)(10.54)(5.64)
Weighted Avg Shares32.95M41.93M48.53M51.89M55.46M
Weighted Avg Shares (Diluted)34.01M42M48.61M51.89M55.46M

DNA Earnings Waterfall · TTM

NYSE:DNA · Revenue to Net Income

Key Ratios

EPS$-5.37
Gross Margin70.0%
Net Margin-248.8%
P/E Ratio-1.9
P/S Ratio16.5

Analysis

$141.3M of revenue converted into -$304.4M of net income for the selected period. Gross margin is 70.0% and net margin is -248.8%, showing how much revenue survives after costs and taxes. EPS is $-5.37, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportOct 29, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 21, 2026

How much revenue does DNA generate?

Ginkgo Bioworks Holdings, Inc. (DNA) reported $170.16M of revenue in fiscal 2025.

Is DNA profitable?

Ginkgo Bioworks Holdings, Inc. (DNA) reported -$312.76M of net income, with a net margin of -183.8%.